SCHEMBL19986562

SCHEMBL19986562

CCCC(C)CCC(C)S

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.46
ACE2 Q9BYF1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20610005 0.84 TSHR (0.59) TSHRACE2
SCHEMBL18286447 0.83 ACE2 (0.43) TSHRACE2
SCHEMBL18256105 0.83 ACE2 (0.43) TSHRACE2
SCHEMBL23737 0.81
SCHEMBL56451 0.80
SCHEMBL5933366 0.79
Ammonia Solution, Strong SCHEMBL28536285 0.78
Ammonia Solution, Strong SCHEMBL8081472 0.77
SCHEMBL1171009 0.77
SCHEMBL5933352 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10294200-B2 Mixed branched eicosyl polysulfide compositions and methods of making same CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2019-05-21 US disclosed
US-10040758-B2 Mixed decyl mercaptans compositions and methods of making same CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-08-07 US disclosed
US-20180079718-A1 Mixed Decyl Mercaptans Compositions and Methods of Making Same CHEVRON PHILLIPS CHEMICAL COMPANY LP 2018-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10294200-B2 Mixed branched eicosyl polysulfide compositions and methods of making same C1S, MRPS35, C5 TSHR 3235/4885ACE2 3508/4885
US-10040758-B2 Mixed decyl mercaptans compositions and methods of making same MGMT, BHMT2, TMT1A TSHR 2221/4885ACE2 3363/4885
US-20180079718-A1 Mixed Decyl Mercaptans Compositions and Methods of Making Same MGMT, BHMT2, TMT1A TSHR 2221/4885ACE2 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.